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ABSTRACT 
Human papillomavirus (HPV) infection is the most common sexually transmitted 
infection worldwide and has been linked to several cancers, including cervical cancer. In the 
United States, the Southern region has a disproportionate burden of cervical cancer, and research 
about the epidemiology of HPV in the region is scarce. This study estimates the prevalence and 
correlates of HPV infection among 14–59 year-old females. 
Data from 4,250 females aged 14–59 years collected during the 2007–2010 National 
Health and Nutrition Examination Survey (NHANES) were used. We estimated the prevalence 
of HPV infection for the South and the rest of the country. We performed weighted chi-square 
test and logistic regression to examine the association between HPV infection and various 
demographics. 
Among 14–26 year-old females, the prevalence of high-risk oncogenic HPV types was 
25.6% (95% confidence (CI): 22.4 ̶ 33.3) in the South and 29.1% (95% CI: 24.8 ̶ 33.8) in the rest 
of the country (p= 0.15). Among 27–59 year-old women, infection from high-risk oncogenic 
types was 20.9% (95% CI: 17.4 ̶ 24.9) in the South compared to 14.5% (95% CI: 12.9 ̶ 16.3) in 
the rest of the country (p=0.0001). 
This study found a higher prevalence of infection from high-risk oncogenic types among 
27 ̶ 59 year-old females in the South compared to the rest of the country, but not among the 14 ̶ 
26 year-olds. These findings highlight the importance of promoting HPV vaccination as well as 
cervical cancer screening, particularly in the Southern region. 
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INTRODUCTION 
Human papillomavirus (HPV) is the most common sexually transmitted infection 
worldwide (World Health Organization, 2016) and has been consistently linked to head, neck, 
pharyngeal, and anogenital cancers (Forman et al., 2012). Over 100 HPV types infect humans, and 
40 of these HPV types infect mainly the anogenital tract (Franco, Duarte-Franco, & Ferenczy, 
2001). Most HPV-related cancers result from infections from HPV types 16 and 18 (Muñoz et al., 
2003). According to their association with pre-malignancy and invasive cancer, HPV types are 
classified as high or low risk oncogenic, and non-oncogenic (Bosch, Lorincz, Muñoz, Meijer, & 
Shah, 2002; Franco et al., 2001; Wright, Denny, & Kuhn, 2000). 
Among HPV-related cancers, cervical cancer is the most prevalent. Cervical cancer 
disproportionately affects women in developing and underdeveloped countries. In developed 
countries, cervical cancer affects poor and disadvantaged women (International Agency for 
Research on Cancer, 2014). In the United States, cervical cancer mainly affects disadvantaged, 
poor women with limited access to healthcare such as those living in the Appalachia and the 
Southern region (Horner et al., 2011). The United States is divided into four census regions: The 
West, the Midwest, the Northeast, and the South. The South is comprised of 17 states: Delaware, 
District of Columbia, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, West 
Virginia, Alabama, Kentucky, Mississippi, Tennessee, Arkansas, Louisiana, Oklahoma, and Texas 
(U.S. Census Bureau, 2013b). In 2013, the national cervical cancer incidence was 7.2 per 100,000. 
The five states with the highest cervical cancer incidence rates were all located in the South: 
Arkansas (10.6 per 100,000), Oklahoma (9.5), Alabama (9.1), Tennessee (8.9), and Texas (8.7) 
(U.S. Statistics Working Group, 2016). 
Women residing in the Southern region are disproportionately affected by cervical cancer.  
However, research studies estimating the prevalence of HPV infection and associated socio-
demographic and behavioral characteristics in the region are lacking. Such information is crucial 
to increase HPV vaccination and cervical cancer screening in order to reduce disparities. We 
estimated the prevalence of HPV infection from oncogenic and non-oncogenic types and examined 
the correlates of HPV infections in the American South using the National Health and Nutrition 
Examination Survey (NHANES) data. 
METHODS 
Study design and population  
NHANES data are collected through a multifaceted probability sampling strategy (Curtin, 
Lester et al., 2013). The detailed methodologies have been published elsewhere (Curtin, Lester et 
al., 2013; Zipf et al., 2013). Dwelling units were randomly selected, and individuals of any age 
were randomly selected to participate in the survey. Any individual who was selected was 
considered eligible for the survey. NHANES data collection occurred in two stages: a home 
interview and a health examination. After the home interview survey, participants were invited to 
the Mobile Examination Center (MEC) for computer-assisted personal interview (CAPI) 
questionnaires, Audio computer-assisted personal self-interview (ACASI) health examination, and 
biological specimen collection (Zipf et al., 2013). The NHANES survey process was explained to 
each sample individual. Subsequently, informed consent was obtained from each selected adults. 
Parents and guardians gave permission for minors to participate, and minors provided assent prior 
to participation. Consent was obtained from the home interview and then for the health 
examination (Zipf et al., 2013).  
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From 2003 to 2010, females 14 ̶ 59 years were asked to self-collect vaginal samples. A 
systematic review comparing self-collected and physician-collected samples for low- and high-
risk types HPV DNA detection from 18 studies estimated the average detection rate at 27.4% for 
self-sampling and 28.0% for physician-sampling (Petignat et al., 2007).  
Two NHANES survey cycles, 2007 ̶ 2008 and 2009 ̶ 2010, were combined for the analysis. 
For the 2007 ̶ 2008 NHANES survey cycle, 78.4% of individuals screened for eligibility consented 
for the home interview. Participation rates were 79.4% for the home interview for the 2009 ̶ 2010 
cycle (National Centers for Health Statistics, 2013). Among selected females, the response rate for 
health examination was 75.5% in the 2007 ̶ 2008 cycle and 77.4% for the 2009 ̶ 2010 cycle 
(National Centers for Health Statistics, 2013). NHANES reports HPV test results as positive, 
negative, inadequate or missing for 40 HPV types. A total of 4,250 females aged 14 ̶ 59 years 
provided adequate self-collected vaginal samples for HPV DNA detection from 2007 to 2010. 
Based on HPV vaccine eligibility, the sample was divided into those still eligible for HPV vaccine 
(14 ̶ 26 years) and those no longer eligible (27 ̶ 59 years).    
Variables 
HPV infection status was the outcome of interest.  Following the classification scheme 
developed by several researchers (Bosch et al., 2002; Bouvard et al., 2009; Franco et al., 2001), 
HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59 were classified as high risk oncogenic 
types. HPV types 6, 11, 16, 18, 31, 33, 35, 39, 40, 42, 45, 51, 52, 53, 55, 56, 58, and 59 were 
classified as oncogenic types. The remaining HPV types were classified as non-oncogenic. 
Females who tested positive for at least one of the high-risk oncogenic types were classified as 
being infected with high-risk oncogenic HPV types. The same criterion was used for any 
oncogenic types. HPV infection status, race/ethnicity, country of birth, country of citizenship, 
federal poverty level, health insurance status, healthcare utilization variables, HPV infection status, 
use of contraception, duration of contraception use, age at first sexual intercourse, and number of 
lifetime partners were included in the analysis. Smoking, although an important covariate, could 
not be included in the analysis due to missing data, especially in the 14 ̶ 26 years age-group.   
Participants’ state of residence were not publicly available. As a result, publicly available 
variables−socio-demographics, sexual behavior, reproductive health, and HPV infection 
status−along with the restricted variables were merged by a staff at the Restricted Data Center. 
The dataset was not released to the investigators but was accessed and analyzed at the Restricted 
Data Center in Atlanta, Georgia. For several variables, the levels were combined to prevent the 
reporting of small cell sizes that could potentially lead to the identification of participants. First, 
the respondents’ region of residence rather than the state was specified in the dataset used for the 
analysis. Additionally, not every state was sampled in any given survey cycle. As a result, the four 
U.S. Census regions were used in the analysis rather than the nine U.S. Census divisions. 
Moreover, the race/ethnicity categories were non-Hispanic White, non-Hispanic Black, Mexican 
American, other Hispanic, and other (including multiracial individuals). Individuals in the “other” 
category comprised about 6% of the sample. Mexican Americans, other Hispanics, and individuals 
of other racial and ethnic groups were combined. The study was granted exempt status by the 
investigators’ Institutional Review Board.   
Statistical Analysis 
STATA svy (StataCorp, 2013) commands were used to conduct the analyses to account for 
the complex multistage study design and sample weight. Since two survey cycles were combined, 
we followed NHANES guidelines to compute the new MEC sample weight for the analysis. 
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Women 14 ̶ 59 years of age from all racial/ethnic groups were included in the analysis. The 
proportion of respondents who tested positive for high-risk oncogenic, any oncogenic, and non-
oncogenic types HPV for 2007 ̶ 2010 were computed for the South separately and the three other 
regions combined (Northeast, Midwest, and West).  
A 95% confidence interval was computed for each proportion. Weighted chi-square 
analyses were performed to examine the association between HPV infection and important 
demographic, healthcare utilization, and sexual behavior variables. Variables that were 
significantly associated with HPV infection were included in a stepwise multivariable logistic 
regression to identify factors independently associated with HPV infection among sexually active 
women. Interactions were not examined due to the modest sample size. We performed analysis 
with all females for whom the variables and outcome of interest were present. A 5% significance 
level was used for all analyses.  
RESULTS  
Unadjusted HPV Prevalence 
14–26 year-old females.  Among 14–26 year-old females, the prevalence of infection from 
high-risk oncogenic types was 25.6% (95% CI: 22.4 ̶ 33.3) in the South and 29.1% (95% CI: 24.8 ̶ 
33.8) in the rest of the country (p=0.15). The prevalence of infection from any oncogenic types 
was 31.7% (95% CI: 26.4 ̶ 37.6) in the South and 32.3% (95% CI: 27.9 ̶ 36.9) in other regions 
(p=0.84). Non-oncogenic types HPV prevalence was 36.5% (95% CI: 30.0 ̶ 43.4) in the South and 
31.9% (95% CI: 26.9 ̶ 37.4) in the other regions (p=0.08) (Table 1).   
27 ̶ 59 year-old women.  Among 27–59 year-old women, infection from high-risk 
oncogenic types was 20.9% (95% CI: 17.4 ̶ 24.9) in the South compared to 14.5% (95% CI: 12.9 ̶ 
16.3) in other regions (p=0.0001). For infection from any oncogenic types, infection rates were 
24.0% (95% CI: 19.9 ̶ 28.7) and 17.9% (95% CI: 16.3 ̶ 19.5) for the South and other regions 
respectively (p=0.0001).  Non-oncogenic types HPV prevalence was 32.4% (95% CI: 29.6 ̶ 35.4) 
in the South and 28.1% (95% CI: 26.3 ̶ 30.1) in the other regions (p=0.014) (Table 1).   
Demographics Associated with HPV Infection  
14–26 year-old females.  Infection from high-risk oncogenic types varied significantly by 
history of contraceptive use, sexual activity status, and number of lifetime sex partners in both the 
South and the rest of the country (Table 2) whereas infection from any oncogenic types varied by 
race/ethnicity, history of contraceptive use, sexual activity status, and number of lifetime sex 
partners (Table 2).   
27–59 year-old women.  Among 27–59 year-old women residing in the South as well as 
those residing in the rest of the country, infection from high-risk oncogenic types varied 
significantly by race/ethnicity, marital status, poverty index, insurance status, and number of 
lifetime sex partners (Table 3). Infection from any oncogenic types varied by race/ethnicity, 
marital status, poverty index, insurance status, and number of lifetime sex partners in both the 
Southern region and the rest of the country (Table 3).   
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Table 1. Prevalence of high-risk oncogenic, oncogenic, and non-oncogenic types HPV  
14-26 year-old females Regiona p-value 
South (n=532) Otherb  (n=811) 
High-risk oncogenicc types infection 
  
0.15 
Yes 25.6 (22.4-33.3) 29.1 (24.8-33.8) 
 
No 74.4 (66.7-77.5) 70.9 (66.2-75.2) 
 
Any oncogenicd types infection 
  
0.84 
Yes 31.7 (26.4-37.6) 32.3 (27.9-36.9) 
 
No 68.3 (62.4-73.6) 67.7 (63.0-72.1) 
 
Non-oncogenice types infection 
  
0.08 
Yes 36.5 (30.0-43.4) 31.9 (26.9-37.4) 
 
No 63.4 (56.6-69.9) 68.1 (62.6-73.1) 
 
27-59 year-old females South (n=1,066) Other b (n=1841) 
 
High-risk oncogenicc types infection 
  
0.0001 
Yes 20.9 (17.4-24.9) 14.5 (12.9-16.3) 
 
No 79.1 (75.1-82.6) 85.5 (83.7-87.1) 
 
Any oncogenicd types infection 
  
0.0001 
Yes 24.0 (19.9-28.7) 17.9 (16.3-19.5) 
 
No 76.0 (71.3-80.1) 82.1 (80.5-83.7) 
 
Non-oncogenice types infection 
  
0.014 
Yes 32.4 (29.6-35.4) 28.1 (26.3-30.1) 
 
No 67.6 (64.6-70.4) 71.9 (69.9-73.7) 
 
aTo prevent potential disclosure, the region rather than the state of residence was included in the dataset 
bNortheast, West, and Midwest combined 
cHPV  types: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59  
dHPV types: 6, 11, 16, 18, 31, 33, 35, 39, 40, 42, 45, 51, 52, 53, 55, 56, 58, and 59 
eAll other HPV types 
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Table 2. Socio-demographic and behavioral characteristics associated with infection from high-risk types among 14-26 year-
old females 
 
 
 
 
 
HR Oncogenica types Any oncogenicb types HPV 
Characteristics 
South (n= 532 ) Otherb (n=811) South (n= 532 ) Otherb (n=811) 
Infection 
Status 
p-value Infection 
Status 
p-value Infection 
Status 
p-value Infection 
Status 
p-value 
Yes No Yes No 
 
Yes No Yes No 
Race/Ethnicity % % 0.04 %  %  0.2 %  %  0.015 %  %  0.14 
Non-Hispanic White 44.2 55.7 
 
65.6 63.0 
 
43.6 56.7 
 
65.6 62.8 
 
Non-Hispanic Black 34.2 19.0 
 
11.4 8.9 
 
34.4 18.0 
 
11.7 8.7 
 
Hispanic and Other   21.6 25.3 
 
23.0 28.1 
 
22.0 25.3 
 
22.7 28.5 
 
Country of birth 
  
0.28 
  
0.7 
  
0.15 
  
0.8 
US 89.9 88.0 
 
86.5 88.4 
 
90.8 87.4 
 
87.4 88.0 
 
Other 10.1 12.0 
 
13.5 11.6 
 
9.2 12.8 
 
12.6 12.0 
 
Country of citizenship 
  
0.58 
  
0.9 
     
0.6 
US 93.8 92.0 
 
91.7 91.6 
 
94.4 92.2 0.35 92.3 91.3 
 
Other 6.2 7.4 
 
8.3 8.4 
 
5.6 7.8 
 
7.7 8.7 
 
Marital status 
  
0.5 
  
0.00001 
  
0.5 
  
0.00001 
Married 22.5 31.3 
 
4.8 25.2 
 
23.4 31.6 
 
5.1 26.7 
 
Never married   65.3 65.3 
 
69.3 53.2 
 
64.2 55.3 
 
69.4 51.7 
 
Divorced/separated/widowed 12.2 13.1 
 
25.9 21.6 
 
12.4 13.1 
 
25.5 21.6 
 
Poverty index 
  
0.45 
  
0.03 
  
0.3 
  
0.3 
<100% 35.6 25.2 
 
26.1 24.4 
 
36.2 24.3 
 
26.6 24.0 
 
100-299% 22.8 25.5 
 
23.6 20.1 
 
21.9 26.1 
 
23.8 19.8 
 
300-499% 27.4 30.8 
 
29.1 24.4 
 
29.6 29.9 
 
27.5 25.0 
 
≥ 500%  14.2 18.5 
 
21.2 31.1 
 
12.3 19.7 
 
22.1 31.2 
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Health insurance 
  
0.55 
  
0.036 
  
0.6 
  
0.02 
Yes  69.1 74.3 
 
68.3 79.3 
 
70.3 
  
67.6 80.2 
 
No 30.9 25.7 
 
31.7 20.7 
 
29.7 74.0 
 
32.4 19.8 
 
Type of place most often go for 
healthcare  
  
0.39 
  
0.7 
 
26.0 0.13 
  
0.8 
Doctor's office 60.3 66.9 
 
74.0 71.8 
 
56.6 69.0 
 
71.6 72.8 
 
Other 39.7 33.1 
 
26.0 28.2 
 
43.4 31.0 
 
28.4 27.2 
 
No. of healthcare visits last 
year 
  
0.69 
  
0.8 
  
0.92 
  
0.5 
None 10.4 13.2 
 
12.2 10.8 
 
11.9 12.7 
 
12.9 10.3 
 
≤3  57.2 52.2 
 
50.1 52.2 
 
54.7 53.1 
 
48.8 53.0 
 
≥4 32.4 34.6 
 
37.7 37.0 
 
33.4 34.2 
 
38.3 36.7 
 
Ever taken birth control pills 
  
0.005 
  
0.0001 
  
0.0005 
  
0.0001 
Yes 70.2 45.6 
 
62.2 42.5 
 
69.8 44.4 
 
63.3 41.2 
 
No 29.8 54.4 
 
37.8 57.5 
 
30.2 55.6 
 
36.7 58.8 
 
No. of years of birth control 
pills 
  
0.51 
  
0.5 
  
0.11 
  
0.8 
<2 43.2 47.6 
 
44.4 50.8 
 
41.8 48.9 
 
44.2 51.4 
 
≥2 56.8 52.4 
 
55.6 49.2 
 
58.2 51.1 
 
55.8 48.6 
 
Ever had sex  
  
0.00001 
  
0.00001 
  
0.00001 
  
0.00001 
Yes 95.5 67.1 
 
95.0 62.7 
 
95.2 65.7 
 
95.4 61.2 
 
No 4.5 32.9 
 
5.0 37.3 
 
4.8 34.3 
 
4.6 38.8 
 
Age at first sexual intercourse 
  
0.96 
  
0.6 
  
0.8 
  
0.5 
9-14 years 23.8 23.9 
 
25.5 22.4 
 
23.1 24.3 
 
25.4 22.2 
 
>= 15 years  76.2 76.1 
 
74.5 77.6 
 
76.9 75.7 
 
74.6 77.8 
 
No. of lifetime sex partners  
  
0.00001 
  
0.00001 
  
0.00001 
  
0.00001 
≤3 20.5 66.3 
 
27.3 64.7 
 
22.0 68.9 
 
27.0 67.0 
 
≥4 79.5 33.7 
 
72.7 35.3 
 
78.0 31.1 
 
73.0 33.0 
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No. of sex partners 5+ years 
older  
  
0.52 
  
0.002 
  
0.08 
  
0.001 
None 71.1 75.8 
 
59.0 75.9 
 
68.3 78.1 
 
59.2 76.9 
 
≥1 28.9 24.2 
 
41.0 24.1 
 
31.7 21.9 
 
40.8 23.1 
 
aHPV types: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59  
bHPV types: 6, 11, 16, 18, 31, 33, 35, 39, 40, 42, 45, 51, 52, 53, 55, 56, 58, and 59 
cNortheast, West, and Midwest combined 
 
Table 3.  Socio-demographic and behavioral characteristics associated with infection from high-risk oncogenic types among 
27-59 year-old females 
 
HR Oncogenica types Any oncogenicb types HPV 
Characteristics 
South (n= 1,066 ) Otherc (n=1841) South (n=1,066) Otherc (n= 1,841) 
Infection Status p-value Infection Status p-value Infection Status p-value Infection Status p-value 
Yes No 
 
Yes No Yes No Yes No 
Race/Ethnicity %  %  0.017 % % 0.004 %  %  0.02 %  %  0.015 
Non-Hispanic White 57.9 59.0 
 
64.8 73.1 
 
56.9 59.4 
 
66.4 73.1 
 
Non-Hispanic Black 26.1 18.9 
 
13.8 7.3 
 
25.9 18.6 
 
12.5 7.3 
 
Hispanic and Other  16.0 22.1 
 
21.5 19.6 
 
17.2 22.0 
 
21.2 19.6 
 
Country of birth 
  
0.04 
  
0.9 
  
0.02 
  
0.7 
US 91.0 83.2 
 
82.4 82.1 
 
90.8 82.9 
 
83.7 81.9 
 
Other 9.0 16.8 
 
17.6 17.9 
 
9.2 17.1 
 
16.3 18.1 
 
Country of citizenship 
  
0.06 
  
0.6 
  
0.15 
  
0.32 
US 93.5 90.6 
 
91.3 90.2 
 
93.3 90.5 
 
92.0 90.0 
 
Other 6.5 9.4 
 
8.7 9.2 
 
6.7 9.5 
 
8.0 10.0 
 
Marital status 
  
0.00001 
  
0.00001 
  
0.00001 
  
0.00001 
Married 38.1 66.6 
 
36.1 65.9 
 
39.6 67.4 
 
40.1 66.2 
 
Never married  18.4 8.9 
 
20.3 11.4 
 
18.1 8.6 
 
17.4 11.7 
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Divorced/separated/widowed 43.5 24.5 
 
43.6 22.7 
 
42.3 24.0 
 
42.4 22.1 
 
Poverty index 
  
0.008 
  
0.0002 
  
0.006 
  
0.001 
<100% 27.9 16.8 
 
21.9 10.9 
 
27.2 16.5 
 
20.0 10.9 
 
100-299% 22.3 21.5 
 
22.1 16.6 
 
23.3 21.2 
 
21.3 16.5 
 
300-499% 27.7 26.8 
 
19.9 28.9 
 
28.1 26.6 
 
21.3 29.0 
 
≥ 500%  22.1 34.9 
 
36.1 43.6 
 
21.4 35.6 
 
37.4 43.6 
 
Health insurance 
  
0.006 
  
0.02 
  
0.004 
  
0.05 
Yes  64.2 76.9 
 
79.2 85.6 
 
64.0 77.5 
 
80.8 85.5 
 
No 35.8 23.1 
 
20.8 14.4 
 
36.0 22.5 
 
19.2 14.5 
 
Type of place most often go for 
healthcare  
  
0.7 
  
0.01 
  
0.4 
  
0.01 
Doctor's office 76.1 77.5 
 
71.0 77.3 
 
74.8 77.9 
 
71.6 77.5 
 
Other 23.9 22.5 
 
29.0 22.7 
 
25.2 22.1 
 
28.4 22.5 
 
No. of healthcare visits last 
year 
  
0.5 
  
0.041 
  
0.8 
  
0.4 
None 14.9 12.0 
 
13.3 12.0 
 
13.6 12.3 
 
12.4 12.2 
 
≤3  47.8 48.8 
 
55.5 48.5 
 
48.5 48.6 
 
52.9 48.7 
 
≥4 37.3 39.2 
 
31.2 39.5 
 
37.9 39.1 
 
34.8 39.1 
 
Ever taken birth control pills 
  
0.97 
  
0.43 
  
0.9 
  
0.9 
Yes 83.7 83.6 
 
84.8 82.8 
 
83.2 83.7 
 
83.3 83.1 
 
No 16.3 16.4 
 
15.2 17.2 
 
16.8 16.3 
 
16.7 16.9 
 
No. of years of birth control 
pills 
  
0.15 
  
0.04 
  
0.2 
  
0.08 
<2 30.6 25.0 
 
34.1 25.2 
 
30.4 24.9 
 
32.6 25.2 
 
≥2 69.4 75.0 
 
65.9 74.8 
 
69.6 75.1 
 
67.4 74.8 
 
Ever had sex 
  
0.15 
  
0.14 
  
0.5 
  
0.2 
Yes 98.2 98.3 
 
98.8 97.7 
 
97.9 97.4 
 
98.6 97.7 
 
No 1.8 1.8 
 
1.2 2.3 
 
2.1 2.6 
 
1.4 2.3 
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Age at first sexual intercourse 
  
0.47 
  
0.016 
  
0.3 
  
0.0003 
9-14 years 17.3 13.9 
 
14.1 9.9 
 
18.0 13.5 
 
15.5 90.6 
 
>= 15 years  82.7 86.1 
 
85.9 90.1 
 
82.0 86.5 
 
84.5 9.2 
 
No. of lifetime sex partners  
  
0.0004 
  
0.00001 
  
0.004 
  
0.00001 
≤3 21.8 38.7 
 
20.3 41.4 
 
21.7 39.4 
 
21.6 42.0 
 
≥4 78.2 61.3 
 
79.7 58.6 
 
78.3 60.6 
 
78.4 58.0 
 
No. of sex partners 5+ years 
older  
  
0.17 
  
0.0002 
  
0.3 
  
0.003 
None 58.1 72.7 
 
58.4 75.2 
 
62.0 71.9 
 
60.2 75.6 
 
≥1 41.9 27.3 
 
41.6 24.8 
 
38.0 28.1 
 
39.8 24.4 
 
 
 aHPV  types: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59  
bHPV types: 6, 11, 16, 18, 31, 33, 35, 39, 40, 42, 45, 51, 52, 53, 55, 56, 58, and 59 
cNortheast, West, and Midwest combined 
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Predictors of HPV Infection among Sexually Active Women 
14–26 year-old females.  Among 14–26 year-old females in the South, those whose income 
was 300–499% above the federal poverty level had lower odds of infection from high-risk 
oncogenic types compared to those whose income was below the federal poverty level (adjusted 
odds ratio (aOR)= 0.36; p< 0.01).  Additionally, females who had four or more lifetime sex 
partners had greater odds of infection with high-risk oncogenic types compared to those who had 
three or fewer sex partners (aOR= 8.27; p<0.001) (Table 4).  Among 14–26 year-old females living 
in other regions, those who have never been married had greater odds to be infected with high-risk 
oncogenic types compared to those who were married (aOR= 12.79; p<0.001), and those who were 
divorced or separated had higher odds of infection (aOR= 6.09; p<0.001). Those who had four or 
more sex partners had higher odds of infection compared to those who had three partners or fewer 
(aOR=4.03; p<0.001) (Table 4).     
For infection from any oncogenic types in the South, females whose income was 300–
499% above the poverty index had lower odds of infection compared to those whose income was 
below the poverty index (aOR= 0.45; p<0.05) (Table 4). Southern females who had insurance 
coverage had higher odds of infection compared to those who had no coverage (aOR=2.48; 
p<0.01). Those who had four or more sex partners had higher odds of infection compared to those 
who had three partners or fewer (aOR=8.51; p<0.001). For females in other regions, females who 
have never been married had greater odds to be infected with high-risk oncogenic types compared 
to those who were married (aOR= 14.1; p<0.001), and those who were divorced or separated had 
higher odds of infection (aOR= 6.13; p<0.001).  Additionally, females who had four or more sex 
partners had higher odds of infection compared to those who had three partners or fewer 
(aOR=4.40; p<0.001) (Table 4).     
27–59 year-old females.  Among 27–59 year-old women in the South, those who have 
never been married had increased odds to be infected with high-risk oncogenic types (aOR= 5.14; 
p<0.01) compared to married women. Those who had four or more sex partners had higher odds 
of infection compared to those who had three partners or fewer (aOR=1.32; p<0.05) (Table 4). In 
the other regions, women who have never been married (aOR= 2.38; p<0.01) and those who were 
previously married (aOR= 4.26; p<0.05) had higher odds of infection from high-risk oncogenic 
types.  Women with household income 300–499% above the poverty index had lower odds to be 
infected (aOR= 0.26; p<0.01).  Additionally, women who had one or more sex partners at least 
five years older (aOR= 1.84; p<0.01) and who had four or more sex partners (aOR= 3.78; p<0.01) 
had greater odds to be infected (Table 4). 
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Table 4. Odds of HPV infections among sexually active 14 ̶ 59 year-old females by socio-demographic and sexual behavioral 
characteristics   
14-26 year-old females 27-59 year-old females 
Characteristics 
HR onocogenica types HPV  Any oncogenicb types 
HPV 
HR oncogenica types HPV Any oncogenicb types HPV 
South  Otherc  South Otherc  South Otherc  South Otherc   
aORd aORd aORd aORd aORd aORd aORd aORd 
Race/Ethnicity 
        
Non-Hispanic 
White 
Ref. Ref. Ref. Ref. Ref. Ref. Ref. Ref. 
              Non-
Hispanic Black 
1.79 (0.62-
5.2) 
0.85 (0.35-
2.1) 
1.73 (0.74-
4.0) 
1.09 (0.47-
2.6) 
0.72 (0.32-
1.7) 
0.63 (0.25-
1.6) 
0.88 (0.36-
2.1) 
0.52 (0.22-
1.2) 
Hispanic and Other  1.21 (0.56-
2.6) 
0.73 (0.39-
1.4) 
1.32 (0.60-
2.94) 
0.69 (0.40-
1.19) 
0.57 (0.24-
1.3) 
0.76 (0.31-
1.8) 
0.71 (0.39-
1.29) 
0.78 (0.36-
1.7) 
Marital status 
        
Married Ref. Ref. Ref. Ref. Ref. Ref. Ref. Ref. 
Never married  1.56 (0.44-
5.5) 
12.79(4.8-
34.1)*** 
1.33 (0.18-
1.4) 
14.1 (6.3-
31.4)*** 
5.14 (1.7-
15.2)** 
2.38 (1.23-
4.6)** 
4.27 (1.44-
12.6)** 
2.20 (1.34-
3.61)** 
Divorced/separated
/ widowed 
1.62 (0.47-
5.5) 
6.09 
(2.2=16.6)**
* 
1.41 (0.36-
5.5) 
6.13 (2.4-
15.8)*** 
2.98 (0.98-
9.1) 
4.26 (1.37-
13.3)* 
2.09 (0.69-
7.5) 
4.16 (1.76-
9.8)** 
Poverty index 
        
<100% Ref. Ref. Ref. Ref. Ref. Ref. Ref. Ref. 
100-299% 0.59 (0.25-
1.4) 
1.79 (0.51-
6.2) 
0.50 (0.17-
1.4) 
2.18 (0.59-
8.0) 
0.57 (0.15-
2.2) 
0.51 (0.19-
1.4) 
0.56 (0.15-
2.2) 
0.58 (0.26-
1.3) 
300-499% 0.36 (0.17-
0.75)** 
1.59 (0.65-
3.9) 
0.41 (0.17-
0.99)* 
1.32 (0.57-
3.1) 
1.12 (0.52-
2.4) 
0.26 (0.10-
0.66)** 
1.32 (0.50-
3.5) 
0.34 (0.15-
0.78)* 
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≥ 500%  0.52 (0.13-
2.2) 
1.01 (0.31-
3.2) 
0.36 (0.07-
1.9) 
1.16 (0.41-
3.3) 
0.79 (0.33-
1.9) 
0.57 (0.25-
1.28) 
0.80 (0.38-
1.7) 
0.69 (0.31-
1.5) 
Health insurance 
        
No Ref. Ref. Ref. Ref. Ref. Ref. Ref. Ref. 
Yes 2.17 (0.79-
5.9) 
0.66 (0.27-
1.6) 
2.48 (1.23-
5.02)** 
0.60 (0.24-
1.51) 
0.58 (0.27-
1.2) 
0.92 (0.30-
2.78) 
0.45 (0.20-
1.02) 
0.97 (0.32-
2.9) 
No. of sex partners 
5+ years older  
        
None Ref. Ref. Ref. Ref. Ref. Ref. Ref. Ref. 
≥1 0.65 (0.24-
1.8) 
1.32 (0.66-
2.7) 
0.94 (0.44-
1.97) 
1.43 (0.68-
3.0) 
1.92 (0.45-
8.3) 
1.84 (1.13-
3.0)** 
1.64 (0.40-
7.1) 
1.57 (0.92-
2.6) 
No. of lifetime sex 
partners  
        
≤3 Ref. Ref. Ref. Ref. Ref. Ref. Ref. Ref. 
≥4 8.27 (2.8-
24.4)*** 
4.03 (2.2-
7.4)*** 
8.51 (3.7-
19.6)*** 
4.40 (2.4-
8.2)*** 
1.32 (1.02-
2.23)* 
3.78 (1.6-
9.0)** 
1.43 (0.8-
2.53)  
3.9 (1.9-
8.0)*** 
Age at first sexual 
intercourse 
        
9-14 years 
    
Ref. Ref. Ref. Ref. 
≥ 15 years  
    
1.26 (0.5-
3.2) 
0.87 (0.59-
1.3) 
.07 (0.42-
2.74) 
0.47 (0.24-
0.93)* 
aHPV  types: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59  
bHPV types: 6, 11, 16, 18, 31, 33, 35, 39, 40, 42, 45, 51, 52, 53, 55, 56, 58, and 59 
 cNortheast, West, and Midwest combined 
dadjusted odds ratio 
*p<0.05; ** p<0.01; *** p<0.001  
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For any oncogenic types, in the South, women who have never been married had higher 
odds of infection (aOR= 4.27; p<0.01).  In the rest of the country, women who have never been 
married had greater odds to be infected (aOR= 2.20; p<0.01) and those who were divorced, 
separated, or widowed also had increased odds to be infected (aOR= 4.16; p<0.01). Women whose 
income was 300–499% above the poverty index had lower odds of infection from any oncogenic 
types (aOR= 0.34; p<0.01).  Those who had four or more sex partners had higher odds of infection 
(aOR= 3.90; p<0.001), and those who had their sexual debut at 15 years or older had lower odds 
to be infected with any oncogenic types compared those who had their sexual debut at 14 years or 
younger (aOR= 0.47; p<0.01) (Table 4).  
DISCUSSION 
Cervical cancer is more prevalent in the South compared to the rest of the United States, 
and this study found the prevalence of HPV infections from high-risk oncogenic types to be higher 
in the South than the rest of the United States among women aged 27 ̶ 59 years, but not among 
those 14 ̶ 26 year-old. A study estimated HPV prevalence among women in the Appalachia, a 
region with high rates of cervical cancer and predominantly non-Hispanic White population, and 
found higher prevalence of high-risk infection among Appalachian women (Reiter et al., 2013) 
when compared to the national estimates for non-Hispanic White females (Hariri et al., 2011; 
Reiter et al., 2013). The difference in the prevalence of infection from high-risk and any oncogenic 
types among 27 ̶ 59 year-old females in the South compared to the rest of the country appears to 
be smaller than the difference in cervical cancer incidence and mortality. Therefore, this difference 
in the prevalence of HPV infection from high-risk oncogenic types is not large enough to account 
for the higher prevalence of cervical cancer in the South.    
Among 14 ̶ 26 year-olds, the prevalence of infection from high-risk oncogenic or any 
oncogenic HPV types was not higher in the South compared to the rest of the country. Using the 
2003 ̶ 2006 and the 2007 ̶ 2010 NHANES survey periods, a study investigated the change in the 
prevalence of infection from HPV types 6, 11, 16, or 18 (Markowitz et al., 2013) and found that 
among females aged 14 ̶ 19 years, HPV infection prevalence declined from 11.5% in 2003 ̶ 2006 
to 5.1% in 2007  ̶2010. A similar decline was not observed in the older age-groups (Markowitz et 
al., 2013). Comparable rates of infection from high-risk or any oncogenic types among 14 ̶ 26 year-
olds between the South and the rest of the country are probably due to the national decline in HPV 
infection in the vaccine-eligible age-group.   
Among 14 ̶ 26 year-old females residing in the South, those living at 300−499% federal 
poverty level had lower odds of infection from high-risk and any oncogenic HPV types compared 
to those living below 100% federal poverty level. Among 27 ̶ 59 year-old females residing in other 
regions, the odds of infection from high-risk and any oncogenic HPV types were lower among 
those living at 300−499% federal poverty level compared to those living below 100% federal 
poverty level. Previous studies have reported that higher income and higher education levels are 
associated with lower rates of HPV infection (Hariri et al., 2011; Shi, Devarakonda, Liu, Taylor, 
& Mills, 2014). The present study also found sexually active, unmarried women to have greater 
odds of infection from any oncogenic and high-risk oncogenic types. Several studies have reported 
a higher prevalence of HPV infection among unmarried women (Bui et al., 2017; Dunne et al., 
2007; Kahn, Lan, & Kahn, 2007; Reiter et al., 2013). The absence of a long-term and committed 
sex partner facilitates multiple or short-term sexual partnerships. This may help explain the higher 
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prevalence of infection from high-risk and any oncogenic types observed among unmarried 
sexually active women.  
Among 14 ̶ 26 year-old females, this study found that having four or more lifetime sex 
partners was positively associated with infection from high-risk and any oncogenic types in the 
South and the rest of the country. However, among 27 ̶ 59 year-old females, having four or more 
lifetime sex partners was positively associated with infection from high-risk and any oncogenic 
types in the rest of the country but not in the South. Previous research has reported that increasing 
number of lifetime sex partners was associated with HPV infection (Dunne et al., 2007; 
Markowitz, Sternberg, Dunne, McQuillan, & Unger, 2009; Reiter et al., 2013; Thorsteinsson et 
al., 2016). It is not clear as to why the increasing number of sex partners was not associated with 
infection from high-risk or any oncogenic types in the South. 
There were several limitations to this study. First, sexual behaviors were self-reported, 
which can be biased by poor recall and social desirability. Most individuals are not enthusiastic 
about revealing their sexual practices due to social stigma, embarrassment, or fear of disclosure 
(Brener, Billy, & Grady, 2003; Kelly, Soler-Hampejsek, Mensch, & Hewett, 2013; O’Sullivan, 
2008). Consequently, such behaviors may be underrepresented. In the same vein, previous research 
has reported that responses to sexual behavior questionnaire through ACASI are generally more 
accurate compared to face-to-face interviews (Ghanem, Hutton, Zenilman, Zimba, & Erbelding, 
2005; Phillips, Gomez, Boily, & Garnett, 2010). NHANES collects sexual behavior data using 
ACASI thereby reducing social desirability bias in this study; the survey also accounts for 
participant non-response and collects health information from a nationally representative sample 
which is robust against selection bias. These aspects lend to more reliable and valid findings. 
Additionally, missing data were a limitation to this study as it hindered the analysis of HPV 
infection risk factors by different racial and ethnic groups, smaller age-groups, and smaller 
geographic divisions. Moreover, due to the risk of potential disclosure, several levels of variables 
had to be combined, and some important variables, such as smoking, had to be excluded from the 
analysis altogether. Further, religious affiliation influences attitudes toward HPV vaccine uptake 
(Thomas, Blumling, & Delaney, 2015), but its association with HPV infection could not be 
analyzed as such data were not collected in the survey. Despite the limitations, this study 
contributes to the literature addressing geographic disparities in HPV infection. In the future, racial 
and ethnic groups, such as American Indians (Centers for Disease Control and Prevention, 2016; 
Watson et al., 2014) and Vietnamese (Ma et al., 2012), who experience disparities in HPV-related 
diseases should be oversampled in national surveys collecting HPV samples to facilitate 
investigations of disparities in HPV infections.  
CONCLUSION 
This study estimated the prevalence of infection among females for the South and the rest 
of the country and found a higher prevalence of infection from high-risk oncogenic and any 
oncogenic HPV types among 27 ̶ 59 year-old females residing in the South compared to the rest 
of the country, but not among the 14 ̶ 26 year-olds. Women in the Southern region remain at higher 
risk of developing and dying from cervical cancer, and the higher prevalence of infection from 
high-risk and any oncogenic HPV types among 27 ̶ 59 year-olds in the South partially explains the 
higher prevalence of cervical cancer in the South.  However, this difference in HPV prevalence 
seems to be smaller than the difference in cancer incidence between the South and other regions. 
This suggests that the disparities in cervical cancer incidence and mortality are not only being 
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driven by the differences in the epidemiology of HPV alone, but also by disparities in cervical 
cancer screening. Efforts to make cervical cancer screening accessible to disadvantaged women 
and those at higher risk of infection must continue in order to reduce disparities in cervical cancer 
incidence and mortality.  
Among 14 ̶ 26 year-olds, the prevalence of infection from high-risk oncogenic and any 
oncogenic HPV types is relatively high in the South and the rest of the country. These findings 
reiterate the need for HPV vaccination to be administered to pre-teens, prior to their sexual debut.  
Additionally, females aged 14 ̶ 26 years are still eligible for HPV vaccination catch-up. 
Consequently, healthcare providers should recommend the vaccine to 14 ̶ 26 year-old females even 
if they are already infected with one HPV type as they can be protected from other HPV types 
covered by the vaccine.    
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